BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Clovis Oncology (CLVS) To Announce Second Quarter 2014 Financial Results And Host Webcast Conference Call On August 7 7/22/2014 12:21:41 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In TIGER2 Study 6/23/2014 12:19:44 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In RUCAPANC Study 6/16/2014 10:31:57 AM
Clovis Oncology (CLVS) Shares Drop As Analysts Give Edge To Lung-Cancer Rival 6/4/2014 7:05:16 AM
Clovis Oncology (CLVS) Announces Encouraging Data From Phase 1/2a Study Evaluating Lucitanib In Advanced Solid Tumors 6/2/2014 9:42:46 AM
Clovis Oncology (CLVS)’s CO-1686 Demonstrates Compelling Clinical Activity And Progression-Free Survival (PFS) In Updated Phase 1/2 Study Results In Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) 6/2/2014 9:38:18 AM
Clovis Oncology (CLVS)’s Phase 1 Study Of Rucaparib Demonstrates Compelling Clinical Activity and Safety In Patients With Solid Tumors 6/2/2014 9:36:49 AM
Clovis Oncology (CLVS) Wins Breakthrough Status For Lung Cancer Candidate CO-1686 5/20/2014 7:20:15 AM
Clovis Oncology (CLVS) Announces Clinical Data To Be Presented At 2014 American Society of Clinical Oncology Annual Meeting 5/15/2014 8:02:02 AM
Clovis Oncology (CLVS) Announces First Quarter 2014 Operating Results 5/9/2014 7:31:06 AM
123456789